Trial intelligence / Profile preview

EPPIC-Net Platform Protocol for Painful Diabetic Peripheral Neuropathy

NCT05476276Phase 2Completed

Start
Sep 2022
Primary completion
Aug 2025
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in diabetic peripheral neuropathy (DPN) (2 arms). Primary endpoint: Daily 0-10 pain Numeric Rating Scale. Started Sep 2022; status: completed.

02

Conditions

diabetic peripheral neuropathy (DPN)

Beyond the preview

Go deeper on NCT05476276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05476276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call